Emerging Infectious Diseases (Feb 2004)

Introduction of SARS in France, March–April, 2003

  • Jean-Claude Desenclos,
  • Sylvie van der Werf,
  • Isabelle Bonmarin,
  • Daniel Levy-Bruhl,
  • Yazdan Yazdanpanah,
  • Bruno Hoen,
  • Julien Emmanuelli,
  • Olivier Lesens,
  • Michel Dupon,
  • François Natali,
  • Christian Michelet,
  • Jacques Reynes,
  • Benoit Guery,
  • Christine Larsen,
  • Caroline Semaille,
  • Yves Mouton,
  • Daniel Christmann,
  • Michel André,
  • Nicolas Escriou,
  • Anna Burguière,
  • Jean-Claude Manuguerra,
  • Bruno Coignard,
  • Agnés Lepoutre,
  • Christine Meffre,
  • Dounia Bitar,
  • Bénédicte Decludt,
  • Isabelle Capek,
  • Denise Antona,
  • Didier Che,
  • Magid Herida,
  • Andréa Infuso,
  • Christine Saura,
  • Gilles Brücker,
  • Bruno Hubert,
  • Dominique LeGoff,
  • Suzanne Scheidegger

DOI
https://doi.org/10.3201/eid1002.030351
Journal volume & issue
Vol. 10, no. 2
pp. 195 – 200

Abstract

Read online

We describe severe acute respiratory syndrome (SARS) in France. Patients meeting the World Health Organization definition of a suspected case underwent a clinical, radiologic, and biologic assessment at the closest university-affiliated infectious disease ward. Suspected cases were immediately reported to the Institut de Veille Sanitaire. Probable case-patients were isolated, their contacts quarantined at home, and were followed for 10 days after exposure. Five probable cases occurred from March through April 2003; four were confirmed as SARS coronavirus by reverse transcription–polymerase chain reaction, serologic testing, or both. The index case-patient (patient A), who had worked in the French hospital of Hanoi, Vietnam, was the most probable source of transmission for the three other confirmed cases; two had been exposed to patient A while on the Hanoi-Paris flight of March 22–23. Timely detection, isolation of probable cases, and quarantine of their contacts appear to have been effective in preventing the secondary spread of SARS in France.

Keywords